138 related articles for article (PubMed ID: 32365349)
1. Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1.
van Leeuwaarde RS; Pieterman CRC; May AM; Dekkers OM; van der Horst-Schrivers AN; Hermus AR; de Herder WW; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
Neuroendocrinology; 2021; 111(3):288-296. PubMed ID: 32365349
[TBL] [Abstract][Full Text] [Related]
2. High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; Pieterman CRC; Bleiker EMA; Dekkers OM; van der Horst-Schrivers AN; Hermus AR; de Herder WW; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2018 Jun; 103(6):2354-2361. PubMed ID: 29618015
[TBL] [Abstract][Full Text] [Related]
3. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
[TBL] [Abstract][Full Text] [Related]
4. Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1.
van den Broek MFM; van Nesselrooij BPM; Pieterman CRC; Verrijn Stuart AA; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Havekes B; Kerstens MN; Bisschop PH; Valk GD
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32396602
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1).
Berglund G; Lidén A; Hansson MG; Oberg K; Sjöden PO; Nordin K
Fam Cancer; 2003; 2(1):27-33. PubMed ID: 14574164
[TBL] [Abstract][Full Text] [Related]
6. Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
van Vliembergen ENM; Eijkelenkamp H; Valk GD; Vriens MR; Meijer GJ; Intven MPW; de Laat JM
Front Endocrinol (Lausanne); 2023; 14():994370. PubMed ID: 37305036
[TBL] [Abstract][Full Text] [Related]
7. Financial burden is associated with worse health-related quality of life in adults with multiple endocrine neoplasia type 1.
Peipert BJ; Goswami S; Helenowski I; Yount SE; Sturgeon C
Surgery; 2017 Dec; 162(6):1278-1285. PubMed ID: 28923697
[TBL] [Abstract][Full Text] [Related]
8. Care for patients with multiple endocrine neoplasia type 1: the current evidence base.
Pieterman CR; Vriens MR; Dreijerink KM; van der Luijt RB; Valk GD
Fam Cancer; 2011 Mar; 10(1):157-71. PubMed ID: 21061174
[TBL] [Abstract][Full Text] [Related]
9. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
[TBL] [Abstract][Full Text] [Related]
10. Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.
Horiuchi K; Okamoto T; Iihara M; Tsukada T
Surg Today; 2013 Aug; 43(8):894-9. PubMed ID: 23052745
[TBL] [Abstract][Full Text] [Related]
11. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors.
Nell S; Borel Rinkes IHM; Verkooijen HM; Bonsing BA; van Eijck CH; van Goor H; de Kleine RHJ; Kazemier G; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; Vriens MR;
Ann Surg; 2018 Feb; 267(2):352-356. PubMed ID: 27811505
[TBL] [Abstract][Full Text] [Related]
12. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
[TBL] [Abstract][Full Text] [Related]
13. Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I.
Goswami S; Peipert BJ; Helenowski I; Yount SE; Sturgeon C
Surgery; 2017 Dec; 162(6):1270-1277. PubMed ID: 28919050
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
[TBL] [Abstract][Full Text] [Related]
16. MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; Dreijerink KM; Ausems MG; Beijers HJ; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Peeters PHM; Pijnappel RM; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2017 Jun; 102(6):2083-2090. PubMed ID: 28323962
[TBL] [Abstract][Full Text] [Related]
17. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
19. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.
Sadowski SM; Pieterman CRC; Perrier ND; Triponez F; Valk GD
Endocr Relat Cancer; 2020 Jun; 27(6):R145-R161. PubMed ID: 32229700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
